HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differentiation in embryonal neuroepithelial tumors of the central nervous system.

Abstract
Ninety-six embryonal neuroectodermal tumors were studied histologically and immunohistologically with a panel of antibodies including glial, neuronal, epithelial, mesodermal, and myelin markers. In 71 tumors there was glial and neuronal differentiation and expression both of an S (photoreceptor) antigen and vimentin. In five tumors there was only glial differentiation and in 20 tumors only neuronal differentiation. No reactivity for myelin and epithelial markers was found. Histologic and immunohistologic findings identified various degrees of differentiation in different tumors, which was bipolar (glial and neuronal) in most tumors and unipolar in the remainder. The authors suggest that their findings may be the result of normal or aberrant oncogenic differentiation, agreeing with the nomenclature of the World Health Organization classification for these tumors with and the inclusion of a category for ependymoblastoma.
AuthorsF F Cruz-Sánchez, M L Rossi, J T Hughes, T H Moss
JournalCancer (Cancer) Vol. 67 Issue 4 Pg. 965-76 (Feb 15 1991) ISSN: 0008-543X [Print] United States
PMID1846772 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Differentiation
  • Glial Fibrillary Acidic Protein
  • Nerve Tissue Proteins
  • S100 Proteins
  • Vimentin
Topics
  • Adolescent
  • Adult
  • Antigens, Differentiation (analysis)
  • Brain Neoplasms (pathology)
  • Child
  • Child, Preschool
  • Ependymoma (pathology)
  • Female
  • Ganglioneuroma (pathology)
  • Glial Fibrillary Acidic Protein (analysis)
  • Humans
  • Immunohistochemistry
  • Infant
  • Male
  • Medulloblastoma (pathology)
  • Middle Aged
  • Neoplasms, Germ Cell and Embryonal (pathology)
  • Nerve Tissue Proteins (analysis)
  • Neuroblastoma (pathology)
  • Pinealoma (pathology)
  • Retinoblastoma (pathology)
  • S100 Proteins (analysis)
  • Spinal Cord Neoplasms (pathology)
  • Vimentin (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: